Form 4: Broadwood Partners Increases Stake in STAAR Surgical Co with Recent Stock Purchases

Broadwood Partners, along with related entities and individuals, has increased its holdings in STAAR Surgical Co through a series of open market purchases.

Summary

• Broadwood Partners, L.P. has reported changes in beneficial ownership of STAAR Surgical Co stock.
• The transactions involve purchases of common stock on March 18, 2025, and March 20, 2025.
• On March 18, 2025, Broadwood Partners purchased 58,734 shares at a weighted average price of $17.4086 and 34,390 shares at a weighted average price of $17.7614.
• On March 20, 2025, Broadwood Partners purchased 108,720 shares at a weighted average price of $17.9635.
• Following these transactions, Broadwood Partners directly owns 12,182,995 shares.
• Neal C. Bradsher, as President of Broadwood Capital, Inc. (General Partner of Broadwood Partners), may be deemed to indirectly beneficially own these shares.
• Neal C. Bradsher also directly owns 25,900 shares.
• The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects standard trading activity by a major shareholder. The increased stake could be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.

Positives

• Broadwood Partners' increased investment in STAAR Surgical Co could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

This activity is typical for investment firms that hold significant positions in publicly traded companies. Monitoring Form 4 filings provides insights into the investment strategies and confidence levels of major shareholders.

Stakeholder Impact

• The increased stake by Broadwood Partners could positively influence shareholder confidence.

Key Dates

Keywords

STAAR Surgical, Broadwood Partners, Beneficial Ownership, Stock Purchase, Form 4, STAA